Chun-Ming Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chun-Ming Chen has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Chun-Chieh Tseng
Combination Medical Device Technology Division, Medical Devices R&D Service Department, Metal Industries Research & Development Centre, Kaohsiung 81160, Taiwan
1 shared publication - Min-Wen Wang
Department of Mechanical Engineering, National Kaohsiung University of Science and Technology, Kaohsiung, TAIWAN
1 shared publication - Wei-Young Wang
Mechanical Engineering Department, National Kaohsiung University of Science and Technology, Kaohsiung City 807618, Taiwan
1 shared publication
Latest Publications
- Open Access
- 7 May 2025
- Published by MDPI AG in Journal of Manufacturing and Materials Processing
- Vol. 9 (5) , 154
Mechanical and Cellular Evaluations of ACP-Enriched Biodegradable Micromolded PLA/PCL Bone Screws
Nanoscale amorphous calcium phosphate (ACP) exhibits superior bioactivity, degradability, and osteoblast adhesion compared to hydroxyapatite (HAp), making it a promising bioactive ceramic material for bone regeneration applications. This study explores the integration of ACP as a bioactive additive in polylactic acid/polycaprolactone (PLA/PCL) composites. Nanoscale ACP powder was synthesized through low-temperature wet chemical methods without additional reagents. The composite, consisting of 10 wt.% ACP, 80 wt.% PLA, and 20 wt.% PCL, achieved optimal tensile strength (>12 MPa) and elongation (>0.1%). Utilizing the Taguchi experimental design, the microinjection molding parameters were optimized, and they are a material temperature of 190 °C, an injection speed of 50 mm/s, and a holding pressure speed of 30 mm/s. Variance analysis identified the injection speed to be the most significant factor, contributing 50.73% to the overall effect. Immersing ACP in simulated body fluid (SBF) for six hours reduced its calcium ion concentration by 28%, with this concentration stabilizing thereafter. Biocompatibility was confirmed through an MTT assay with NIH-3T3 cells, demonstrating the PLA/PCL/ACP composite’s compatibility. Bone differentiation and mineralization tests showed the enhanced performance of both ACP and the composite material. Degradation tests indicated an initial 0.29% weight increase in the first week, followed by a 2% reduction by the fifth week. These results underscore the PLA/PCL/ACP composite’s excellent mechanical properties, biocompatibility, and suitability for injection molding, positioning it as a strong candidate for biodegradable bone screw applications.
- 7 May 2025
- Published by MDPI AG in Journal of Manufacturing and Materials Processing
- Vol. 9 (5) , 154
Open AccessMechanical and Cellular Evaluations of ACP-Enriched Biodegradable Micromolded PLA/PCL Bone Screws
Nanoscale amorphous calcium phosphate (ACP) exhibits superior bioactivity, degradability, and osteoblast adhesion compared to hydroxyapatite (HAp), making it a promising bioactive ceramic material for bone regeneration applications. This study explores the integration of ACP as a bioactive additive in polylactic acid/polycaprolactone (PLA/PCL) composites. Nanoscale ACP powder was synthesized through low-temperature wet chemical methods without additional reagents. The composite, consisting of 10 wt.% ACP, 80 wt.% PLA, and 20 wt.% PCL, achieved optimal tensile strength (>12 MPa) and elongation (>0.1%). Utilizing the Taguchi experimental design, the microinjection molding parameters were optimized, and they are a material temperature of 190 °C, an injection speed of 50 mm/s, and a holding pressure speed of 30 mm/s. Variance analysis identified the injection speed to be the most significant factor, contributing 50.73% to the overall effect. Immersing ACP in simulated body fluid (SBF) for six hours reduced its calcium ion concentration by 28%, with this concentration stabilizing thereafter. Biocompatibility was confirmed through an MTT assay with NIH-3T3 cells, demonstrating the PLA/PCL/ACP composite’s compatibility. Bone differentiation and mineralization tests showed the enhanced performance of both ACP and the composite material. Degradation tests indicated an initial 0.29% weight increase in the first week, followed by a 2% reduction by the fifth week. These results underscore the PLA/PCL/ACP composite’s excellent mechanical properties, biocompatibility, and suitability for injection molding, positioning it as a strong candidate for biodegradable bone screw applications.